Planta Med 2025; 91(04): 167-172
DOI: 10.1055/a-2523-3856
Reviews

Real-World Data to Document the Use of Herbal Medicinal Products in Children – Report of a Workshop in Krakow

Nico Symma
1   Pharma Deutschland e. V., Bonn, Germany
,
2   Institute of Pharmaceutical Biology and Phytochemistry, University of Münster, Germany
5   Foundation Plant for Health, Neumarkt, Germany
,
Bernd Roether
3   Bionorica SE, Neumarkt, Germany
5   Foundation Plant for Health, Neumarkt, Germany
,
1   Pharma Deutschland e. V., Bonn, Germany
5   Foundation Plant for Health, Neumarkt, Germany
,
4   Institute of Pharmaceutical Sciences – Pharmacognosy, University of Graz, Austria
5   Foundation Plant for Health, Neumarkt, Germany
› Institutsangaben
Preview

Abstract

The workshop “Real-world data to document the use of phytopharmaceuticals in children” was organized by the GA Foundation Plants for Health in collaboration with multiple international scientific societies on July 14, 2024, during the International Congress on Natural Products Research in Kraków, Poland. The event focused on leveraging real-world data and real-world evidence to support the use of herbal medicinal products (syn. phytopharmaceuticals) in pediatric care. The workshop aimed to discuss the current state and future approaches for utilizing real-world data/real-world evidence in expanding the use of herbal medicinal products in children and adolescents. Therefore, the workshop highlighted the unmet needs and challenges in documenting the effectiveness and safety of herbal medicinal products in children and emphasized the coordinated exchange and collaboration among academia, industry, and regulatory authorities. After an e-symposium in May 2022 with more than 300 participants and an in-person workshop on this topic in Bonn in June 2023, this workshop in Krakow was the third event of its kind hosted by the Foundation Plants for Health. Participants concluded that interdisciplinary collaboration is highly needed to establish qualified methods of data collection and assessment of real-world data, e.g., establishing requirements to incorporate nonprescription herbal medicinal products into electronic patient records and registries that can be accessed by all stakeholders.



Publikationsverlauf

Eingereicht: 21. November 2024

Angenommen nach Revision: 20. Januar 2025

Artikel online veröffentlicht:
11. Februar 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany